Clinuvel To Build Vitiligo Pipeline And Commercial Presence
This article was originally published in The Pink Sheet Daily
Executive Summary
Following EU approval last year of its lead sunlight-intolerance product Scenesse, the rare dermatological disease biotech has turned to developing its vitiligo pipeline.